Table 3 Logistic analysis of the risk factors in HSPN patients with crescent formation
Variable | OR (95% CI) | P value |
|---|---|---|
Abdominal pain | 2.119 (0.770–5.833) | 0.1459 |
Recurrence of skin rash≥3times | 2.050 (0.339–12.385) | 0.4341 |
C-reactive protein | 0.990 (0.241–4.069) | 0.9890 |
White blood cell count | 1.288 (0.423–3.922) | 0.6561 |
Platelet count | 1.153 (0.359–3.698) | 0.8113 |
Complement component 3 | 13.666 (0.205–912.816) | 0.2225 |
Total cholesterol | 1.530 (0.523–4.479) | 0.4377 |
Triglyceride | 1.920 (0.567–6.501) | 0.2943 |
24 h urinary microalbumin | > 999.999(< 0.001- > 999.999) | 0.9520 |
24 h urinary total protein | < 0.001(< 0.001- > 999.999) | 0.9374 |
Urinary RBC count | 6.577 (0.646–66.966) | 0.1116 |
Urinary WBC count | 3.300 (1.119–9.739) | 0.0306 |
N-acetylglucosaminidase | 1.799 (0.147–21.969) | 0.6456 |
α1-Microglobulin | 1.856 (0.556–6.196) | 0.3149 |
Urinary transferrin | 1.086 (0.054–21.903) | 0.9572 |
Level of urinary occult blood | 1.749 (0.040–76.622) | 0.7720 |
Level of urinary protein | > 999.999 (< 0.001- > 999.999) | 0.9400 |
Urine microalbumin/creatinine | 25.053 (1.354–463.708) | 0.0305 |